| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | $3.1M+138.5% | $1.3M-20.7% | $1.7M-4.3% | $1.7M+97.0% | $878K |
| Selling, general and administrative | $4.8M+50.7% | $3.2M | — | — | — |
| Total operating expenses | $7.9M+76.5% | $4.5M-47.5% | $8.5M-17.9% | $10.4M+85.8% | $5.6M |
| Loss from operations | -$7.9M-76.5% | -$4.5M+45.7% | -$8.2M+18.4% | -$10.1M-79.3% | -$5.6M |
| Change in fair value of derivative liability | $28K | $0 | — | — | — |
| Interest income | $23K+283.3% | $6K+500.0% | $1K-50.0% | $2K | — |
| Interest expense | -$146K | $0 | — | — | — |
| Net other (expense) income | -$95K-1683.3% | $6K+500.0% | $1K-50.0% | $2K+100.1% | -$2.9M |
| Net loss from operations before discontinued operations | -$8.0M-78.8% | -$4.5M | — | — | — |
| Loss from discontinued operations | -$885K+25.3% | -$1.2M | — | — | — |
| Net loss | -$8.9M-57.0% | -$5.7M+31.4% | -$8.2M | — | -$8.5M |
| Net loss per share attributed to common stockholders - basic and diluted (in dollars per share) | -$7840.00+60.2% | -$19680.00+88.9% | -$176800.00-69.5% | -$104320.00-4193.0% | -$2430.00 |
| Weighted-average number of shares - basic and diluted (in shares) | 1.16B+302.1% | 287.4M+516.0% | 46.6M-51.8% | 96.8M-97.2% | 3.49B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.